Andrew White, PA
Physician Assistant · Mesa, AZNPI 1043791247
Payments from drug & device makers
Across 107 payments — averaging $19.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$326
- Boehringer Ingelheim$265
- AstraZeneca$221
- Bayer$165
- Gilead$118
- Merck$116
- plus $889 from 20 others
What the payments were for
- Food & beverage$2,100100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 20 | $326 |
| Boehringer Ingelheim | 15 | $265 |
| AstraZeneca | 8 | $221 |
| Bayer | 8 | $165 |
| Gilead | 5 | $118 |
| Merck | 7 | $116 |
| Abbott | 4 | $109 |
| GSK | 6 | $102 |
| Xeris Pharmaceuticals, Inc. | 5 | $102 |
| Dexcom, Inc. | 3 | $93 |
| Exact Sciences | 5 | $92 |
| Lilly USA, LLC | 4 | $66 |
| Redhill Biopharma Inc. | 2 | $45 |
| Amgen | 2 | $36 |
| Lucid Diagnostics Inc. | 2 | $32 |
| Hologic Sales And Service, LLC | 1 | $31 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $28 |
| Renalytix AI, Inc. | 1 | $21 |
| Cranial Technologies, Inc | 1 | $20 |
| AbbVie | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Pfizer | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Tonix Medicines, Inc. | 1 | $14 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| Qiagen, LLC | 1 | $14 |
How this compares
$2,100 in reported general payments places this provider in the 80th percentile of 2,888 physician assistant providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 51 | $59,082 |
| RybelsusSemaglutide | 32 | $59,042 |
| JardianceEmpagliflozin | 55 | $58,699 |
| FarxigaDapagliflozin Propanediol | 29 | $36,429 |
| EliquisApixaban | 27 | $27,686 |
| TradjentaLinagliptin | 11 | $16,131 |
| TrulicityDulaglutide | 14 | $13,191 |
| JanuviaSitagliptin Phosphate | 12 | $8,976 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $6,972 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 52 | $6,564 |
| Omega-3 Acid Ethyl Esters | 37 | $4,502 |
| Atorvastatin Calcium | 194 | $1,704 |
| LantusInsulin Glargine,hum.Rec.Anlog | 18 | $1,558 |
| Humulin NInsulin Nph Human Isophane | 13 | $1,156 |
| Metformin Hcl | 189 | $1,055 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $326 | $118,12483 claims |
| Boehringer IngelheimJardiance, Tradjenta | $265 | $74,83066 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $221 | $43,40240 claims |
| PfizerEliquis | $17 | $27,68627 claims |
| Lilly USA, LLCTrulicity, Humulin N | $66 | $14,34727 claims |
| MerckJanuvia | $116 | $8,97612 claims |
| Sanofi-aventis U.S. LLCLantus | $17 | $1,55818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Mesa
- Jessica RosenblumMesa$19K
- Katrina McDanielMesa$14K
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
- Alyssa BoschenPhoenix$86K
- Christopher BeroScottsdale$81K
- Katherine MinorPhoenix$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.